NASDAQ: ODTX
Odyssey Therapeutics Revenue

Odyssey Therapeutics revenue was $2.98M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ODTX annual revenue was $3.0M, with -33.5% growth year-over-year.

ODTX past revenue growth

How has ODTX's revenue growth performed historically?

Company
-33.45%
Industry
233.69%
Market
37.77%
ODTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ODTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ODTX revenue history

Current Revenue
$3.0M
Current Earnings
-$148.6M
Current Profit Margin
-4,994.9%

Be the first to know when ODTX announces revenue.

ODTX Revenue History By Year

ODTX Yearly RevenueODTX RevenueODTX ChangeODTX Revenue Growth
2025-12-31$2.98M-$1.50M-33.45%
2024-12-31$4.47MN/AN/A

1 of 1

Odyssey Therapeutics Revenue FAQ

What was ODTX's revenue last quarter?

Odyssey Therapeutics (NASDAQ: ODTX) reported Q4 2025 revenue of N/A up N/A year over year. In the same quarter last year, Odyssey Therapeutics's revenue was N/A.

What was Odyssey Therapeutics's revenue in 2025?

Odyssey Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $2.98 million, a 33.45% decrease year over year.

How much does Odyssey Therapeutics make in a day?

Based on Odyssey Therapeutics annual revenue for the past one years, ODTX makes an average of $8,153.42 per day.

What was Odyssey Therapeutics's annual revenue growth in the past year?

As of Q2 2026, Odyssey Therapeutics's revenue has grown -33.45% year over year. This is 267.14 percentage points lower than the US Biotechnology industry revenue growth rate of 233.69%. Odyssey Therapeutics's revenue in the past year totaled $2.98 million.

How much does Odyssey Therapeutics make in a year?

Odyssey Therapeutics's revenue by year for the past one years is:
  • Odyssey Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $2.98 million, a 33.45% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.